Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2 Published in The Oncologist, July 2024

A targeted drug-delivery device may help some pancreatic cancer patients get chemotherapy with fewer body-wide side effects.

For 70-year-old Roberta Luna, tending to her garden is therapy — especially trimming rosemary, its purple blooms matching the color she wears every day for pancreatic cancer awareness: purple.

Pancreatic cancer is a disease that’s often deadly, but a new treatment is showing promise at a New Jersey hospital. NBC10’s Ted Greenberg explains how it has made a difference for one man who thought he was out of options.